Where is Alector headquartered?

Alector is located in South San Francisco, CA.

Who invested in Alector?

Alector has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Alector?

Alector closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

alector.com

Alector

Alector develops and commercializes antibody therapeutics for the treatment of cancer and neurodegenerative diseases.

Business Model:

Revenue: $133.2M

Employees: 201-500

Geographic Data

Address: 131 Oyster Point Blvd

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

series e

Raised Last:

$133M

Raised Total:

$195M

Social

Facebook

Crunchbase

Metrics

2,886,459Website Global Rank

5,856Website Monthly Traffic

Twitter Followers

Description

Alector develops and commercializes antibody therapeutics for the treatment of cancer and neurodegenerative diseases.

Contact Phone:
+14152315660

Contact Email:

IPO Details

Alector went public on 2/7/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/7/2019

IPO Valuation:
$1B

Ticker Symbol:
ALEC

IPO Price:
$19/share

Amount Raised:
$176M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised
2/2019	INmuneBIO	Post-IPO Equity	0
2/2019	INmuneBIO	Post-IPO Equity	0

Startup Demographics

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2016	Series D	9	$29.5M	Dementia Discovery Fund Topspin Partners Polaris Partners OrbiMed MRL Ventures Fund Mission Bay Capital GV Amgen Ventures AbbVie Biotech Ventures Dementia Discovery Fund
9/2015	Series C	6	$32M	MRL Ventures Fund Topspin Partners Polaris Partners OrbiMed Mission Bay Capital GV MRL Ventures Fund
8/2015	Series C		$32.3M	OrbiMed Polaris Partners Google Ventures Topspin Partners Mission Bay Capital
3/2014	Series B		-
7/2018	Series E	18	$133M	OrbiMed Mission Bay Capital Euclidean Capital GV Polaris Partners Section 32 Deerfield Capital Management Amgen Ventures Mission BioCapital Casdin Capital GV Perceptive Advisors New Leaf Venture Partners MRL Ventures Fund Lilly Asia Ventures OrbiMed Mission Bay Capital Euclidean Capital GV Polaris Partners Section 32 Deerfield Capital Management Amgen Ventures Mission BioCapital Casdin Capital GV
2/2019	IPO		$212.8M
10/2013	Series A	2	-	OrbiMed Polaris Partners OrbiMed Polaris Partners
3/2014	Series B	1	-	Janssen Belgium Janssen Belgium
3/2014	Series B		-	Janssen Pharmaceuticals Janssen Pharmaceuticals
3/2014	Series B	1	-	Janssen Belgium Janssen Belgium
10/2013	Series A	2	-	OrbiMed Polaris Partners OrbiMed Polaris Partners

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details